Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
From their beginnings as a treatment for type 2 diabetes, GLP-1 receptor agonists such as semaglutide and tirzepatide have seen an explosion in use, most popularly for weight loss
The fixed doses represent a higher per-kilogram exposure in lighter individuals, increasing the likelihood of significant GI effects at each step
But sexual health matters
Retatrutide weight loss results: Phase 2 vs Phase 3 TRIUMPH-4 trial data Phase 3: TRIUMPH-4 Results (December 2025) In December 2025, Eli Lilly announced topline results from TRIUMPH-4, the first completed Phase 3 trial for retatrutide
The Bridge program applies only to people with obesity
US$ 26.12
US$ 26.25
US$ 22.53
US$ 29.63
US$ 24.18
US$ 27.37
US$ 20.64
